'Stage iv' diaporamas de présentation

Evidence Based Medicine MDCN 440

1.19k views • 100 slides

1.41k views • 88 slides

PRESSURE ULCERS: The Basics A QUALITY APPROACH

PRESSURE ULCERS: The Basics A QUALITY APPROACH. Bridgepoint I, Suite 300 5918 West Courtyard Drive Austin, TX 78730-5036 1-866-439-5863 www.tmf.org Logo for TMF Health Quality Insurance appears in the upper left hand corner of each slide in this presentation. Objectives.

815 views • 71 slides

Targeted Therapy for Metastatic NSCLC

Targeted Therapy for Metastatic NSCLC. Gregory J. Riely October 14, 2012. Disclosures. Consulting Chugai Ariad Tragara Daiichi Novartis Abbott Foundation Medicine Celgene. Research Funding Novartis Chugai Glaxo SmithKline BMS Infinity Pfizer Merck. Lung Adenocarcinomas.

868 views • 68 slides

Diverticulitis

Diverticulitis. Sandra J. Beck, M.D., F.A.C.S., F.A.S.C.R.S Associate Professor of Surgery University of Kentucky Grand Round February 9, 2011. Objective: To answer frequently asked Questions regarding diverticulitis.

1.76k views • 66 slides

Plant Tissue Culture

Plant Tissue Culture. T.C. Refers to technique of growing plant cells, tissues, organs, seeds or other plant parts in a sterile environment on a nutrient medium. History. In 1902 Haberlandt proposed that single plant cells could be cultured. Haberlandt. did not culture them himself.

1.09k views • 62 slides

Keith T. Flaherty, MD Assistant Professor of Medicine Abramson Cancer Center of the

Clinical Updates Novel Agents for the Treatment of Metastatic Melanoma Future Directions: Opportunities for Targeting B-RAF and Other Targets in Melanoma Management. Keith T. Flaherty, MD Assistant Professor of Medicine Abramson Cancer Center of the University of Pennsylvania

598 views • 42 slides

STAGE IV

NSCLC. STAGE IV. Stage IV NAVELBINE : The pivotal drug GEMZAR : Main competitor TAXOL : Still often prescribed TAXOTERE : New comer. NSCLC Main Drugs. or. NVB - GEM. NVB single agent. Patients not candidate for poly CT. 1 st Line Metastatic NSCLC Stage IV patients.

501 views • 32 slides

P5: February 22, 2008 Weak Gravitational Lensing

489 views • 32 slides

Enhancing Patient Care in Advanced NSCLC Through Clinician-Patient Partnership

Enhancing Patient Care in Advanced NSCLC Through Clinician-Patient Partnership. Program Goals. The All-Knowing Physician: Paternalistic Model. The Information Age. Patient Barriers. Physician Attitudes Toward "Participatory" Patients. Clinician-Patient Partnership.

471 views • 29 slides

518 views • 28 slides

Vocabulary

Vocabulary. Stage IV. agit. DOES. does. CLC IV. neg?tium agit. does business. CLC IV. ?nulus. ?nulum. (m.). ring. CLC IV. c?ra. c?ram. (f.). wax; wax tablet. CLC IV. coquit. cooks. CLC IV. c?r. WHY?. why?. CLC IV. ?/ex. out of. CLC IV. ego. m?. I. I. CLC IV. ?heu.

396 views • 26 slides

Management of Vulval Cancer Services in South West England

Management of Vulval Cancer Services in South West England. Jenny Weeks J Verne L Hirschowitz, V Udaysanker, AD Falconer on behalf SWCIS Gynaecology Tumour Panel. September 2004. SWIS Gynaecology Tumour Panel. 4 Cancer Networks. Multidisciplinary membership. 3 Counties. ASWCS.

1.07k views • 18 slides

Stage IV Multi-sensor Mosaic Development, production and Application at NCEP/EMC

Stage IV Multi-sensor Mosaic Development, production and Application at NCEP/EMC. Ying Lin NOAA/NWS/NCEP/EMC 19-20 Jan 2011. What is the NCEP Stage IV?.

244 views • 17 slides

Univ of AZ WRF Model Verification

Univ of AZ WRF Model Verification. Method. NCEP Stage IV data used for precipitation verification Stage IV is composite of rain fall observations and radar estimates Data has a resolution of 4km http://www.emc.ncep.noaa.gov/mmb/ylin/pcpanl/stage4/

268 views • 14 slides

Dusanka Zupanski, CIRA/CSU Zupanski@CIRA.colostate

OPTIMAL IC. OPTIMAL MODEL ERROR. DIFFERENCE: 2-3 ORDERS OF MAGNITUDE. Dusanka Zupanski, CIRA/CSU Zupanski@CIRA.colostate.edu. TIME EVOLUTION OF OPTIMIZED MODEL ERROR. Dusanka Zupanski, CIRA/CSU Zupanski@CIRA.colostate.edu. TIME EVOLUTION OF OPTIMIZED MODEL ERROR.

167 views • 7 slides

???????????

175 views • 6 slides

OFFICE OF SCIENCE

Office of High Energy Physics, Cosmic Frontier Mid-Scale Dark Energy Spectroscopic Instrument (MS-DESI) Experiment Fermilab PAC Oct. 16, 2012 Kathy Turner DOE, Office of Science, Office of High Energy Physics. OFFICE OF SCIENCE. Dark Energy program planning ? MS-DESI.

141 views • 4 slides

Alignment of R96 with 2012 Amendment of EU 97/68/EC NRMM - Directive

Informal document No . GRPE-64-25 (64th GRPE, June 2012, agenda item 5 (b)). Alignment of R96 with 2012 Amendment of EU 97/68/EC NRMM - Directive. Proposal by EC Inf. GRPE/64/03. Amendment of 97/68/EC. Stage IV limit values mandatory for type approvals 2013 (Q and R)

181 views • 4 slides

Is surgical resection of an asymptomatic primary colorectal tumor beneficial for patients with

Major Morbidity Curative Resection Other Resection Death. 100. 135,000 Colorectal Cancer patients per year. 80. Initial Presentation Stage IV Unresectable Colorectal Cancer Asymptomatic Primary Tumor Good Performance Status. 27,000 (20%) Stage IV. 60. Percent. 7000 (5%)

140 views • 1 slides